Drug Shortage Report for MYLAN-LAMOTRIGINE

Last updated on 2020-12-22 History
Report ID 129861
Drug Identification Number 02265516
Brand name MYLAN-LAMOTRIGINE
Common or Proper name LAMOTRIGINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LAMOTRIGINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2021-02-03
Actual start date
Estimated end date 2021-02-23
Actual end date 2020-12-21
Shortage status Avoided shortage
Updated date 2020-12-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-12-22 French Compare
v3 2020-12-22 English Compare
v2 2020-12-09 French Compare
v1 2020-12-09 English Compare

Showing 1 to 4 of 4